Metuchen Pharmaceuticals is a privately-held healthcare company founded by pharmaceutical industry veterans. The company identifies, acquires, develops and commercializes products that have significant clinical advantages and patent protection. Metuchen has a full range of commercial capabilities including sales, marketing regulatory and medical affairs, finance, trade relations, pharmacovigilance, managed care customer management, manufacturing and distribution. All products are manufactured by well-known third party producers.
The company recently acquired the rights to Stendra® (avanafil tablets), a novel PDE-5 inhibitor for the treatment of erectile dysfunction (ED). Metuchen is currently offering partners the opportunity to license Stendra in Canada, India and South America.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 4400 Route 9 S,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- metuchenpharma.com
- HQ
- Freehold, New Jersey
Metuchen Pharmaceuticals Questions
Metuchen Pharmaceuticals's website is metuchenpharma.com
Metuchen Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/metuchenpharmaceuticals
Metuchen Pharmaceuticals has
7 employees.
View email and phone details for 7
employees at Metuchen Pharmaceuticals.
Metuchen Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Metuchen Pharmaceuticals's top competitors are
Assertio,
Endo,
Agile Therapeutics,
Petros Pharmaceuticals,
Acadia Pharmaceuticals Inc.,
Antares Pharma Inc.,
Mist Pharmaceuticals, Llc,
Eom Pharmaceuticals,
Amneal Pharmaceuticals,
Cosette Pharmaceuticals, Inc..
Metuchen Pharmaceuticals's categories are Pharmaceutical Manufacturing
Metuchen Pharmaceuticals's founding year is 2016
